Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Smallpox future or investigational therapies

Introduction

Overview

Overview

Even though smallpox has been eradicated, there are undergoing studies to identify effective antiviral drugs against smallpox virus due to the potential of an outbreak as a result of bioterrorism.

Future or Investigational Therapies

Future or Investigational Therapies

Since the eradication of the smallpox virus, several antiviral drugs have been studied combating orthopox viruses in general, including:[1]

  • Cidofovir
  • Poxvirus protease inhibitors
  • Compounds targeting host’s intracellular pathways
  • Currently being studied[6]
References

References

  1. ↑ Moore, Zack S; Seward, Jane F; Lane, J Michael (2006). “Smallpox”. The Lancet. 367 (9508): 425–435. doi:10.1016/S0140-6736(06)68143-9. ISSNΒ 0140-6736.
  2. ↑ Smee DF, Sidwell RW (2003). “A review of compounds exhibiting anti-orthopoxvirus activity in animal models”. Antiviral Res. 57 (1–2): 41–52. PMIDΒ 12615302.
  3. ↑ Buller RM, Owens G, Schriewer J, Melman L, Beadle JR, Hostetler KY (2004). “Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model”. Virology. 318 (2): 474–81. doi:10.1016/j.virol.2003.11.015. PMIDΒ 14972516.
  4. ↑ Quenelle DC, Collins DJ, Wan WB, Beadle JR, Hostetler KY, Kern ER (2004). “Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir”. Antimicrob Agents Chemother. 48 (2): 404–12. PMCΒ 321539. PMIDΒ 14742188.
  5. ↑ Painter GR, Hostetler KY (2004). “Design and development of oral drugs for the prophylaxis and treatment of smallpox infection”. Trends Biotechnol. 22 (8): 423–7. doi:10.1016/j.tibtech.2004.06.008. PMIDΒ 15283988.
  6. ↑ Yang H, Kim SK, Kim M, Reche PA, Morehead TJ, Damon IK; et al. (2005). “Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction”. J Clin Invest. 115 (2): 379–87. doi:10.1172/JCI23220. PMCΒ 546427. PMIDΒ 15690085.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: JoΓ£o AndrΓ© Alves Silva, M.D. [2]